Restructuring hitting pharmaceutical sector

Published: 2012-03-08 06:59:00

Updated: 2012-03-08 06:59:00

Korea’s pharmaceutical sector is headed for a fresh round of restructuring, with many companies pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Domestic and foreign drug firms are taking steps to reduce their workforces including s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK